The way we use patient data is changing: We aim to provide the highest quality care. To do this, we routinely collect information about you and the care you receive from us. Like other hospitals across England, we are changing how we share and use this data… Find out more
Pain management
Welcome to The Dudley Group NHS Foundation Trust. This leaflet will provide you and your relatives with information about transforaminal epidural injections. It includes information on what transforaminal epidural injections are, the risks and benefits of them and what the procedure involves.
It is an injection of local anaesthetic and steroid into a specific opening (foramen) at the side of spine where the nerve root comes out. This injection can also be given to a specific nerve root and in this case it is known as a root block or root sleeve injection. The injection can be given in the neck, mid spine or lower back.
The local anaesthetic numbs the nerves in the short term. The steroid can provide long term pain relief for a few weeks or months and any recurring pain may not be as severe as before, but everyone experiences the effects in a different way. Some people have increased pain for the first few days after the injection before the pain gets better.
Steroids have been used for decades for their beneficial effects. Although steroids are not licensed for this specific procedure their use is endorsed by the British Pain Society. The steroids we use act locally and so minimise any side effects.
Overall epidural steroid injections are very safe and serious side effects or complications are rare. However, like all injection procedures there are some risks:
If you experience any of these rare risks, please contact the Pain Management Helpline on 01384 244735, your GP or in an emergency dial 999.
Compared to regular steroid use the steroid injection used for pain procedures is associated with very few side effects, however:
Female patients – you must tell us if you are or might be pregnant. If you are not sure a pregnancy test will be offered.
You do not have to have this injection and your consultant will discuss alternative treatments with you appropriate to your condition. If you prefer, you can continue to take painkilling medication without having any other treatment.
The exception to this information is if you have diabetes. If so, discuss with your doctor what you should do about your diabetes medication.
When you get home, please continue to take any regular medication. It may be necessary for you to take painkillers for a day or two. You might need someone at home to help you but you do not have to stay in bed. The plaster can be removed the next day.
You should gradually increase your level of activity. However, do not take up new exercises until your muscles have had time to adapt. Build up your exercise levels by increasing your physical activity (e.g. walking, swimming, housework) gradually every few days. The eventual aim is to get back to a level of activity that is normal for you.
Some patients will experience immediate pain relief. However, it usually takes 24 to 72 hours for the effects of the steroid medication to take effect and it may be up to one week before the maximum benefits are felt. Some patients will experience mild pain from the procedure that will ease up in a very short amount of time.
How you respond to the injection will be monitored by you on a pain monitoring chart which we will give you to take home. Your further treatment plans will be based on this.
If you have any questions, or if there is anything you do not understand, please contact the Russells Hall Hospital switchboard number on 01384 456111 and ask for the relevant department who issued this leaflet.
If you have any feedback on this patient information leaflet please email dgft.patient.information@nhs.net
This leaflet can be made available in large print, audio version and in other languages, please call 0800 073 0510.
Originator: Ruth Carter, Alifia Tameem. Date originated: March 2021. Review date: January 2024. Next review: October 2026. Version: 5. DGH ref: DGH/PIL/00961.